12 min listen
360 Spotlight: IN8BIO (INAB)
FromSchwab Network
ratings:
Length:
7 minutes
Released:
Oct 14, 2021
Format:
Podcast episode
Description
IN8BIO (INAB) is a clinical-stage biopharmaceutical company focused on therapies for the treatment of cancers. William Ho, President, CEO, and Co-Founder of IN8BIO, discusses the company and how IN8BIO went public via IPO on July 30th. He also talks about how IN8BIO develops gamma-delta T-cell therapies for the treatment of cancer. Tune in to find out more.
Released:
Oct 14, 2021
Format:
Podcast episode
Titles in the series (100)
The Fed's New Targeted Inflation Policy by Schwab Network